Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117799) titled 'A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Pfizer
Condition:
Healthy Adults
Intervention:
Drug: PF-07248144
Drug: PF-07248144
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: February 4, 2025
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/sh...